临床实践中的达里多雷克桑和失眠:意大利睡眠和失眠专家之间的名义组技术共识研究
Luigi Ferini Strambi1, Dario Arnaldi2,3, Enrica Bonanni4
1Sleep Disorders Center, Università Vita-Salute San Raffaele, Milan, Italy.
Current neuropharmacology
|August 8, 2025
概括
达里多雷克桑 (Daridorexant) 是一种双素受体对抗剂,为慢性失眠障碍提供了一种新的治疗方法. 专家的共识强调了它的有效性,在各种人群中的安全性,以及与心理教育的整合,以获得最佳的患者结果.
科学领域:
- 睡眠医学 睡眠医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性失眠障碍 (CID) 对认知,情绪和身体健康产生负面影响.
- 达里多雷克桑 (Daridorexant) 是一种双素受体对抗剂 (DORA),是CID的最新治疗选择.
- 有限的临床证据需要专家的共识来指导达里多雷克桑的应用.
研究的目的:
- 在慢性失眠障碍中使用达里多雷克桑的关键临床问题上建立专家共识.
- 为临床实践提供信息,并指导未来对达里多雷克桑的研究.
- 为了澄清将达里多雷克桑纳纳入失眠管理中的最佳策略.
主要方法:
- 13名意大利睡眠专家使用名义组技术 (NGT).
- 该NGT涉及独立的创意生成,小组讨论和在线投票.
- 为了对临床问题和陈述进行排名,使用了5分利克尔特级别.
主要成果:
- 在五个临床问题中产生了55个陈述,按相关性分类.
- 关键发现涉及达里多雷克桑的机制,安全性,疗效 (夜间/日间) 和长期使用.
- 专家建议从其他催眠药,睡眠精神教育和使用失眠严重性指数和睡眠日记进行评估.
结论:
- 达里多雷克桑特通过双素受体对抗作用提供无睡眠治疗,而无增加镇静作用.
- 它在特殊人群中显示出有效性和安全性,包括老年人和患有并发症的人.
- 专家的共识为达里多雷克桑使用提供了一个框架,强调多学科的方法和进一步的研究.
相关概念视频
01:19Management of Insomnia
322
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
322
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
243
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
243
01:24Substance Use Disorders Affecting Sleep
217
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
217
02:07Blind Procedures
12.1K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.1K
01:27Insomnia
125
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
125
01:23Sedatives and Hypnotics: Overview
647
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
647